Article (Author postprint) (677 Kb) - 
Limited access to UNIGE
Highlights
More informations
Scientific Article
unige:1291 
 |
Erythropoietin protects critically perfused flap tissue |
|
| Authors | ||
| Published in | Annals of Surgery. 2008, vol. 248, no. 6, p. 919-29 | |
| Abstract | OBJECTIVE: The objective of this study was to analyze whether erythropoietin (EPO) protects from necrosis of critically perfused musculocutaneous tissue and the mechanisms by which this protection is achieved. BACKGROUND: EPO is the regulator of erythropoiesis and is used to treat patients with anemia of different causes. Recent studies suggest that EPO has also other tissue-protective effects, irrespective of its erythropoietic properties. MATERIAL AND METHODS: C57BL/6-mice were treated with 3 doses of EPO at 500 IU/kg intraperitoneally. EPO was given either before (preconditioning, n = 7), before and after (overlapping treatment, n = 7), or after (treatment, n = 7) surgery. Animals receiving only saline served as controls (CON). Acute persistent ischemia was induced by elevating a randomly perfused flap in the back of the animals. This critically perfused tissue demonstrates an initial microvascular failure of approximately 40%, resulting in approximately 50% tissue necrosis if kept untreated. Repetitive fluorescence microscopy was performed over 10 days, assessing angiogenesis, functional capillary density, inflammatory leukocyte-endothelial cell interaction, apoptotic cell death, and tissue necrosis. Additional molecular tissue analyses included the determination of inducible nitric oxide synthase, erythropoietin receptor (EPO-R), and vascular endothelial growth factor (VEGF). RESULTS: EPO preconditioning did not affect hematocrit and EPO-R expression, but increased inducible nitric oxide synthase in the critically perfused tissue. This correlated with a significant arteriolar dilation, which resulted in a maintained functional capillary density (CON: 0 +/- 0 cm/cm(2); preconditioning: 37 +/- 21 cm/cm(2); overlapping treatment: 72 +/- 26 cm/cm(2); P < 0.05). EPO pretreatment further significantly reduced microvascular leukocyte adhesion and apoptotic cell death. Moreover, EPO pretreatment induced an early VEGF upregulation, which resulted in new capillary network formation (CON: 0 +/- 0 cm/cm(2); preconditioning: 40 +/- 3 cm/cm(2); overlapping treatment: 33 +/- 3 cm/cm(2); P < 0.05). Accordingly, EPO pretreatment significantly reduced tissue necrosis (CON: 48% +/- 2%; preconditioning: 26% +/- 3%; overlapping treatment: 20% +/- 3%; P < 0.05). Of interest, EPO treatment was only able to alleviate ischemia-induced inflammation but could not improve microvascular perfusion and tissue survival. CONCLUSIONS: EPO pretreatment improves survival of critically perfused tissue by nitric oxide -mediated arteriolar dilation, protection of capillary perfusion, and VEGF-initiated new blood vessel formation. | |
| Keywords | Animals — Arterioles/pathology — Blotting, Western — Capillaries/physiology — Dilatation, Pathologic — Erythropoietin/administration & dosage/pharmacology — Mice — Mice, Inbred C57BL — Microcirculation/physiology — Microscopy, Fluorescence/methods — Necrosis — Neovascularization, Physiologic/drug effects — Nitric Oxide Synthase Type II/physiology — Regional Blood Flow/drug effects — Surgical Flaps/blood supply/pathology — Vascular Endothelial Growth Factor A/metabolism | |
| Identifiers | PMID: 19092336 | |
| Full text | ||
| Structures | ||
| Research group | Groupe Pittet Cuenod Brigitte (chirurgie plastique et reconstructive) (96) | |
| Citation (ISO format) | REZAEIAN, Farid et al. Erythropoietin protects critically perfused flap tissue. In: Annals of Surgery, 2008, vol. 248, n° 6, p. 919-29. https://archive-ouverte.unige.ch/unige:1291 |
251 hits 
0 download 
Contact an author
Update